Zum Hauptinhalt springen

Diamorphin

06. Juni 2023 | Diamorphin

'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England.

'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England. Riley F, Harris M, Poulter HL, Moore HJ, Ahmed D, Towl G, Walker T. Harm Reduct J. 2023 May 12;2…

24. Mai 2023 | Diamorphin

Intravenöse Opioidagonisten-Therapie (OAT) mit Hydromorphon (Hydagelan®) in Wien

Intravenöse Opioidagonisten-Therapie (OAT) mit Hydromorphon (Hydagelan®) in Wien Hans Haltmayer, Ärztlicher Leiter – Suchthilfe Wien gGmbH 25. Substitutions-Forum, 6.Mai 2023, Mondsee Präsentation https://oegabs.at/userfiles/files/substitut…

08. Mai 2023 | Diamorphin

Diamorphinbehandlung – was hat sich getan, was muss getan werden? (Präsentation)

Diamorphinbehandlung – was hat sich getan, was muss getan werden? (Präsentation) Dr. Thomas Peschel Patrida - Praxis für Psychiatrie, Psychotherapie und diamorphingestützte Behandlung 14. Internationaler Akzept Kongress Diese E-Mail-Adresse is…

08. Mai 2023 | Diamorphin

A method of diamorphine (heroin) administration for harm reduction.

A method of diamorphine (heroin) administration for harm reduction. Kavanagh ON, Machado TC. Harm Reduct J. 2023 Mar 30;20(1):44. doi: 10.1186/s12954-023-00758-1. PMID: 36998076; PMCID: PMC10061844. https://www.ncbi.nlm.nih.gov/pmc/ar…

08. Mai 2023 | Diamorphin

Heroin and its metabolites: relevance to heroin use disorder.

Heroin and its metabolites: relevance to heroin use disorder. Milella MS, D'Ottavio G, De Pirro S, Barra M, Caprioli D, Badiani A. Transl Psychiatry. 2023 Apr 8;13(1):120. doi: 10.1038/s41398-023-02406-5. PMID: 37031205; PMCID: PMC1008…

08. Mai 2023 | Diamorphin

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA).

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA). Allen ST, Schneider KE, Rouhani S, White RH, Morris M, Owczarzak J, Sherman SG. Ann Med. 2023 Dec;55(1):2196435. doi…

08. Mai 2023 | Diamorphin

Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment.

Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment. Blawatt S, Arreola LAG, Magel T, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Addict Beh…

Weitere
akutelle Informationen
zu den Themengebieten